# EDCR Study - Etanercept Diamyd Combination Regimen -Open Trial to Evaluate Safety in Children With Type 1 Diabetes

> **NCT02464033** · PHASE2 · COMPLETED · sponsor: **Johnny Ludvigsson** · enrollment: 20 (actual)

## Conditions studied

- Diabetes Mellitus, Type 1

## Interventions

- **DRUG:** GAD-Alum
- **DRUG:** Vitamin D
- **DRUG:** Etanercept

## Key facts

- **NCT ID:** NCT02464033
- **Lead sponsor:** Johnny Ludvigsson
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-05
- **Primary completion:** 2019-02-25
- **Final completion:** 2019-02-25
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2021-03-29

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02464033

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02464033, "EDCR Study - Etanercept Diamyd Combination Regimen -Open Trial to Evaluate Safety in Children With Type 1 Diabetes". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02464033. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*